Medicare

Claim.MD Achieves HITRUST Risk-Based, 2-year (r2) Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

HITRUST Risk-based, 2-year (r2) Certification validates Claim.MD is committed to strong cybersecurity and meeting key regulations to protect sensitive dataPECOS,...

Claim.MD Achieves HITRUST Risk-Based, 2-year (r2) Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

HITRUST Risk-based, 2-year (r2) Certification validates Claim.MD is committed to strong cybersecurity and meeting key regulations to protect sensitive dataPECOS,...

New Disease Modifying Drug for Alzheimer’s Disease Fully Approved by FDA, Highlighting the Crucial Role for Cognetivity in Early Detection and Monitoring

Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetivity Neurosciences' AI CognICA technology poised to play pivotal...

ReWalk Robotics Ltd. to Host Call to Discuss Medicare Proposal to Establish Personal Exoskeletons Within a Benefit Category for Eligible Beneficiaries

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 05, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the...

FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease

Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the...

error: Content is protected !!